title: Photodynamic therapy for posterior capsule neovascularization.
abstract: We report a 71-year-old man with posterior capsule opacification with severe neovascularization who was treated with photodynamic therapy and neodymium:YAG capsulotomy. Treatment was performed using a diode laser at 692 nm, a light dose of 50 J/cm(2), and 6 mg/m(2) body surface area verteporfin. The initial visual acuity was hand motions; 6 months after therapy, the visual acuity was stable at 20/200. In 9 months of follow-up, there was no recurrence of neovascularization and the pupil area remained clear; no retreatment was needed. Photodynamic therapy provided safe and effective occlusion of neovascular vessels in the posterior capsule area.
authors.affiliation: Ophthalmology Department, GATA Haydarpasa Training Hospital, 81030 Selamiçeşme-Kadiköy-Istanbul, Turkey. ali_ayata@yahoo.com
authors.forename: Ali
authors.initials: A
authors.lastname: Ayata
authors.forename: Melih
authors.initials: M
authors.lastname: Unal
authors.forename: Dilaver
authors.initials: D
authors.lastname: Erşanli
authors.forename: Oğuz
authors.initials: O
authors.lastname: Gülecek
authors.forename: Murat
authors.initials: M
authors.lastname: Sönmez
mesh_terms: D000368:Aged; D006801:Humans; D007903:Lens Capsule, Crystalline / Q000098:blood supply* / Q000473:pathology; D008297:Male; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin